Blood derivatives awaken in regenerative medicine strategies to modulate wound healing

Adv Drug Deliv Rev. 2018 Apr:129:376-393. doi: 10.1016/j.addr.2017.12.018. Epub 2017 Dec 28.

Abstract

Blood components play key roles in the modulation of the wound healing process and, together with the provisional fibrin matrix ability to selectively bind bioactive molecules and control its spatial-temporal presentation, define the complex microenvironment that characterize this biological process. As a biomimetic approach, the use of blood derivatives in regenerative strategies has awakened as a source of multiple therapeutic biomolecules. Nevertheless, and despite their clinical relevance, blood derivatives have been showing inconsistent therapeutic results due to several factors, including proper control over their delivery mechanisms. Herein, we highlight recent trends on the use biomaterials to protect, sequester and deliver these pools of biomolecules in tissue engineering and regenerative medicine approaches. Particular emphasis is given to strategies that enable to control their spatiotemporal delivery and improve the selectivity of presentation profiles of the biomolecules derived from blood derivatives rich in platelets. Finally, we discussed possible directions for biomaterials design to potentiate the aimed regenerative effects of blood derivatives and achieve efficient therapies.

Keywords: Biomaterials; Blood derivatives; Delivery; Platelet; Regenerative medicine; Tissue engineering; Wound healing.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Biocompatible Materials / chemistry
  • Biocompatible Materials / pharmacology*
  • Blood Platelets / chemistry*
  • Drug Delivery Systems
  • Humans
  • Regenerative Medicine*
  • Tissue Engineering
  • Wound Healing / drug effects*

Substances

  • Biocompatible Materials